NeoGenomics, Inc.
NEO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $417,465 | $406,124 | $229,553 | $818,621 |
| - Cash | $367,012 | $342,488 | $263,180 | $316,827 |
| + Debt | $605,334 | $611,679 | $610,928 | $612,791 |
| Enterprise Value | $655,787 | $675,315 | $577,301 | $1,114,585 |
| Revenue | $660,566 | $591,643 | $509,728 | $484,329 |
| % Growth | 11.6% | 16.1% | 5.2% | – |
| Gross Profit | $290,100 | $244,604 | $187,896 | $187,060 |
| % Margin | 43.9% | 41.3% | 36.9% | 38.6% |
| EBITDA | -$1,511 | -$17,607 | -$82,331 | -$65,402 |
| % Margin | -0.2% | -3% | -16.2% | -13.5% |
| Net Income | -$78,726 | -$87,968 | -$144,250 | -$8,347 |
| % Margin | -11.9% | -14.9% | -28.3% | -1.7% |
| EPS Diluted | -3.1 | -3.5 | -5.8 | -0.35 |
| % Growth | 11.4% | 39.7% | -1,557.1% | – |
| Operating Cash Flow | $7,023 | -$1,953 | -$65,993 | -$26,723 |
| Capital Expenditures | -$41,061 | -$28,752 | -$30,891 | -$64,142 |
| Free Cash Flow | -$34,038 | -$30,705 | -$96,884 | -$90,865 |